Advanced Life Solutions
Advanced Life Solutions is dedicated to organ preservation for transplantation, providing innovative medical devices and systems to improve graft quality and patient outcomes. Founded in 2016 by expert Silvina Ramella and co-founded with Thierry Asmar, the company aims to advance transplantation technology and support the transplant community through research, development, and strategic partnerships.
Industries
Nr. of Employees
small (1-50)
Advanced Life Solutions
Chavannes-sur-reyssouze, Rhone-Alpes, France, Europe
Products
Perla (organ preservation solution)
A next-generation organ cold-storage preservation fluid composition intended to protect grafts and improve preservation performance and graft lifespan; described as developed and patented by a university group with an exclusive worldwide license held by the company. Product noted as CE mark pending and not approved for clinical use at time of the source content.
Perla (organ preservation solution)
A next-generation organ cold-storage preservation fluid composition intended to protect grafts and improve preservation performance and graft lifespan; described as developed and patented by a university group with an exclusive worldwide license held by the company. Product noted as CE mark pending and not approved for clinical use at time of the source content.
Services
Clinical information and product demonstration for healthcare professionals
Meetings and demonstrations to explain product composition, intended clinical benefits and application in transplantation workflows; appointment-based engagements with transplant clinicians and centres.
Clinical information and product demonstration for healthcare professionals
Meetings and demonstrations to explain product composition, intended clinical benefits and application in transplantation workflows; appointment-based engagements with transplant clinicians and centres.
Expertise Areas
- Organ preservation R&D
- Medical device development for transplantation
- Regulatory compliance (medical devices, CE/MDR) and GDPR
- Quality management and risk-based processes
Key Technologies
- Preservation fluid formulation
- Molecular-pathway–targeted IRI mitigation
- Medical device design for organ preservation
- Preclinical and clinical performance evaluation